Research reportICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor

The present study was planned to evaluate the cholinergic influence on mitochondrial activity and neurodegeneration associated with impaired memory in intracerebroventricular (ICV) streptozotocin (STZ) treated rats. STZ (3 mg/kg), administered ICV twice with an interval of 48 h between the two doses, showed significant impairment in spatial memory tested by water maze test 14 days after first dose without altering blood glucose level and locomotor activity. Animals were sacrificed on 21st day of ICV administration. STZ significantly increased malondialdehyde (MDA), reactive oxygen species (ROS), Ca2+ ion influx, caspase-3 activity and decreased glutathione (GSH) level. Acetylcholinesterase inhibitors tacrine and donepezil (5 mg/kg, PO) pretreatment significantly prevented STZ induced memory deficit, oxidative stress, Ca2+ influx and caspase-3 activity. Carbachol, a muscarinic cholinergic agonist (0.01 mg/kg, SC) did not show any significant effect on ROS generation, Ca2+ ion influx and caspase-3 activity. While nicotinic cholinergic agonist, nicotine, significantly attenuated ICV STZ induced mitochondrial dysfunction and caspase-3 activity. The results indicate that instead of muscarinic receptors nicotinic receptors may be involved in neuroprotection by maintaining mitochondrial functions.

► ICV STZ caused memory impairment in rat alongwith oxidative stress in the brain. ► Nicotine treatment attenuated mitochondrial dysfunction and caspase-3 activity. ► Mitochondrial dysfunction and increase in caspase-3 activity was found in rat brain. ► Central nicotinic receptor emerged as neuroprotective.